![]() |
A compound heterozygous mutation in the
Ji Hyun Kim (Kim JH), Sung Min Cho (Cho SM), Jong-Hee Chae (Chae JH)
Clin Exp Pediatr. 2017;60(3):94-97. Published online 2017 Mar 27 DOI: https://doi.org/10.3345/kjp.2017.60.3.94
|
Citations to this article as recorded by
First Report from Saudi Arabia of Trimethylaminuria Caused by a Premature Stop Codon Mutation in the FMO3 Gene
Bandar Alghanem, Hassan Alamri, Tlili Barhoumi, Imran Ali Khan, Khawlah Almuhalhil, Essra Aloyouni, Hayat Shaibah, Abdullah Mashhour, Shatha Algheribe, Imadul Islam, Mohamed Boudjelal, Majid Alfadhel
The Application of Clinical Genetics.2024; Volume 17: 215. CrossRef A series of simple detection systems for genetic variants of flavin-containing monooxygenase 3 (FMO3) with impaired function in Japanese subjects
Makiko Shimizu, Ami Mizugaki, Natsumi Koibuchi, Haruna Sango, Yumi Uenuma, Hiroshi Yamazaki
Drug Metabolism and Pharmacokinetics.2021; 41: 100420. CrossRef Acroleinâinduced atherogenesis by stimulation of hepatic flavin containing monooxygenase 3 and a protection from hydroxytyrosol
Xiaoyue Wu, Chaofeng Li, Zahula Mariyam, Pan Jiang, Ming Zhou, Falak Zeb, Ijaz ul Haq, Aochang Chen, Qing Feng
Journal of Cellular Physiology.2019; 234(1): 475. CrossRef Development and feasibility of the use of an assessment tool measuring treatment efficacy in patients with trimethylaminuria: A mixed methods study
Krzysztof Rutkowski, Yusof Rahman, Mary Halter
Journal of Inherited Metabolic Disease.2019; 42(2): 362. CrossRef
|